Drucken
Marktanalyse - Analgesics in Mexico
Euromonitor
4 / 2012
45 Seiten
| Typ: | Marktanalyse |
| Sprache: | Englisch |
| Regionen: | Mexiko |
| Verfügbarkeit: | verfügbar |
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
In 2011 the major players in the analgesics category turned to digital advertising in order to grow their share. The analgesics environment is relatively stable, with the majority of sales held by the largest and most established brands. As a result these brands sought to differentiate themselves in 2011, not only through extensive television advertising but also through social media, YouTube and company websites. This channel of advertising is becoming increasingly important as Internet...
Euromonitor International's Analgesics in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's Analgesics in Mexico report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
ANALGESICS IN MEXICO
Euromonitor International
April 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2006-2011
Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011
Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
Table 4 Analgesics Company Shares by Value 2007-2011
Table 5 Analgesics Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Analgesics by Category: Value 2011-2016
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016
Bayer De México SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 1 Bayer de México: Key Facts
Summary 2 Bayer de México: Operational Indicators
Company Background
Production
Summary 3 Bayer de México SA de CV: Production Statistics 2011
Competitive Positioning
Summary 4 Bayer de México SA de CV: Competitive Position 2011
Boehringer Ingelheim Promeco SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 5 Boehringer Ingelheim Promeco SA de CV: Key Facts
Summary 6 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
Company Background
Production
Summary 7 Boehringer Ingelheim Promeco SA de CV: Production Statistics 2011
Competitive Positioning
Summary 8 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2011
Genomma Lab Internacional Sab De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 9 Genomma Lab Internacional SAB de CV: Key Facts
Summary 10 Genomma Lab Internacional SAB de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Genomma Lab Internacional SAB de CV: Competitive Position 2011
GlaxoSmithKline México SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 12 GlaxoSmithKline México SA de CV: Key Facts
Summary 13 GlaxoSmithKline México SA de CV: Operational Indicators
Company Background
Production
Summary 14 GlaxoSmithKline México SA de CV: Production Statistics 2010
Competitive Positioning
Summary 15 GlaxoSmithKline México SA de CV: Competitive Position 2011
Merck-méxico SA in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 16 Merck-México SA: Key Facts
Summary 17 Merck-México SA: Operational Indicators
Company Background
Production
Summary 18 Merck-México SA: Production Statistics 2011
Competitive Positioning
Summary 19 Merck-México SA: Competitive Position 2011
Executive Summary
Consumer Health Achieves Highest Growth Since 2006
Weight Management Grows Substantially
Herbalife Takes Major Step Forward in 2011
Inexpensive Medical Consultation Offices Attract Clients
Government Cracks Down on 'miracle' Products
Key Trends and Developments
Genomma Lab Internacional Sab De Cv Innovates With Flexible and Fast Business Model, Grows Significantly
Antibiotics Law Reinforce Reshapes the Sales of Medicines in the Country
New Demographic Landscape Shapes Health Legislation
Possible New Regulations To Favour International Products
National Health Program Very Active During Calderon Administration
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Market Data
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 13 Consumer Health Brand Shares 2008-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements' Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 20 OTC Switches 2009-2011
Definitions
Sources
Summary 21 Research Sources
Euromonitor International
April 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2006-2011
Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011
Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
Table 4 Analgesics Company Shares by Value 2007-2011
Table 5 Analgesics Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Analgesics by Category: Value 2011-2016
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016
Bayer De México SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 1 Bayer de México: Key Facts
Summary 2 Bayer de México: Operational Indicators
Company Background
Production
Summary 3 Bayer de México SA de CV: Production Statistics 2011
Competitive Positioning
Summary 4 Bayer de México SA de CV: Competitive Position 2011
Boehringer Ingelheim Promeco SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 5 Boehringer Ingelheim Promeco SA de CV: Key Facts
Summary 6 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
Company Background
Production
Summary 7 Boehringer Ingelheim Promeco SA de CV: Production Statistics 2011
Competitive Positioning
Summary 8 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2011
Genomma Lab Internacional Sab De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 9 Genomma Lab Internacional SAB de CV: Key Facts
Summary 10 Genomma Lab Internacional SAB de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Genomma Lab Internacional SAB de CV: Competitive Position 2011
GlaxoSmithKline México SA De Cv in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 12 GlaxoSmithKline México SA de CV: Key Facts
Summary 13 GlaxoSmithKline México SA de CV: Operational Indicators
Company Background
Production
Summary 14 GlaxoSmithKline México SA de CV: Production Statistics 2010
Competitive Positioning
Summary 15 GlaxoSmithKline México SA de CV: Competitive Position 2011
Merck-méxico SA in Consumer Health (mexico)
Strategic Direction
Key Facts
Summary 16 Merck-México SA: Key Facts
Summary 17 Merck-México SA: Operational Indicators
Company Background
Production
Summary 18 Merck-México SA: Production Statistics 2011
Competitive Positioning
Summary 19 Merck-México SA: Competitive Position 2011
Executive Summary
Consumer Health Achieves Highest Growth Since 2006
Weight Management Grows Substantially
Herbalife Takes Major Step Forward in 2011
Inexpensive Medical Consultation Offices Attract Clients
Government Cracks Down on 'miracle' Products
Key Trends and Developments
Genomma Lab Internacional Sab De Cv Innovates With Flexible and Fast Business Model, Grows Significantly
Antibiotics Law Reinforce Reshapes the Sales of Medicines in the Country
New Demographic Landscape Shapes Health Legislation
Possible New Regulations To Favour International Products
National Health Program Very Active During Calderon Administration
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Market Data
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 13 Consumer Health Brand Shares 2008-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements' Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 20 OTC Switches 2009-2011
Definitions
Sources
Summary 21 Research Sources
- Analgesics in Argentina
- Analgesics in Canada
- Analgesics in Denmark
- Analgesics in Guatemala
- Analgesics in Hong Kong, China
- Analgesics in Norway
- Analgesics in Tunisia
- Analgesics in Turkey
- Cough, Cold and Allergy (Hay Fever) Remedies in Argentina
- Cough, Cold and Allergy (Hay Fever) Remedies in Canada
- Cough, Cold and Allergy (Hay Fever) Remedies in Denmark
- Cough, Cold and Allergy (Hay Fever) Remedies in Guatemala
- Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong, China
- Cough, Cold and Allergy (Hay Fever) Remedies in Norway
- Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia
- Cough, Cold and Allergy (Hay Fever) Remedies in Turkey
- Alcohol Addiction – Pipeline Review, H1 2013
- Analgesics in Algeria
- Analgesics in Azerbaijan
- Analgesics in Chile
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Für Sie protokollierte Studien / Marktanalysen:
zuletzt angesehene Studien: